Article

Organ-Specific Treatment for COVID-19: Rationale, Evidence, and Potential Candidates

2020-11-24

Abstract excerpt

<h4>Background: </h4> and Purpose: COVID-19 has become the ongoing public health crisis of our time. Although it was first presented as a respiratory infection, extrapulmonary manifestations are increasingly reported. However, no effective therapeutic strategy for COVID-19 extrapulmonary involvement is currently available. The current study aims to analyze the pathogenesis of COVID-19 extrapulmonary complications...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 630382c6-c03d-5785-a0eb-c7f50cf974b6
DOI: 10.26434/chemrxiv.13274936.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Organ-Specific Treatment for COVID-19: Rationale, Evidence, and Potential CandidatesDOI 10.26434/chemrxiv.13274936.v1Read

Integration of human organoids single-cell transcriptomic profiles and human genetics repurposes critical cell type-specific drug targets for severe COVID-19Semantic proximity Read

Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascadeSemantic proximity Read

Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications.Semantic proximity Read

A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19Semantic proximity Read

MOATAI-VIR - an AI algorithm that predicts severe adverse events and molecular features for COVID-19’s complicationsSemantic proximity Read

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung OrganoidsSemantic proximity Read

The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infectionSemantic proximity Read

A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infectionSemantic proximity Read

Post‐ COVID ‐19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategiesSemantic proximity Read

Human Pluripotent Stem Cell Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory ResponseSemantic proximity Read

Application of Human Induced Pluripotent Stem Cell-Derived Cellular and Organoid Models for COVID-19 ResearchSemantic proximity Read

Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptomeSemantic proximity Read